{"id":144,"date":"2026-07-22T05:42:06","date_gmt":"2026-07-22T05:42:06","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/maximizing-ebitda-selling-dental-practice\/"},"modified":"2026-07-22T05:42:06","modified_gmt":"2026-07-22T05:42:06","slug":"maximizing-ebitda-selling-dental-practice","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/maximizing-ebitda-selling-dental-practice\/","title":{"rendered":"How to Maximize EBITDA Before Selling Your Dental Practice"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li>\n<p>Normalized EBITDA is often the primary metric buyers use to value a dental practice and determine purchase price.<\/p>\n<\/li>\n<li>\n<p>Owners can reduce the risk of price cuts by cleaning financials, tagging add-backs, and normalizing compensation 24\u201336 months before listing.<\/p>\n<\/li>\n<li>\n<p>High-impact EBITDA levers include stronger hygiene production and recall, more high-margin procedures, better PPO contracts, and lower owner dependency.<\/p>\n<\/li>\n<li>\n<p>A sell-side quality-of-earnings review 6\u201312 months before going to market can protect EBITDA and reduce last-minute price reductions.<\/p>\n<\/li>\n<li>\n<p>McLerran &amp; Associates helps owners increase practice value through CPA-led EBITDA analysis and a competitive buyer process, so <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>schedule a free, confidential discovery call today<\/strong><\/a>.<\/p>\n<\/li>\n<\/ul>\n<h2>The Pre-Sale EBITDA Planning Gap<\/h2>\n<p>Most dental practice owners sell once, while buyers negotiate deals every week. That experience gap creates risk in any transition and often shows up during the quality-of-earnings (QoE) review, which is the buyer\u2019s formal audit of your profitability claims. If your add-backs, meaning the legitimate adjustments that convert reported net income into true cash flow, are undocumented or aggressive, the buyer\u2019s QoE team can reject them and push the purchase price down. In a 7-times EBITDA deal, every $50,000 dispute over add-backs changes the purchase price by $350,000, so the add-back discussion can be the most financially significant part of the transaction.<\/p>\n<p>Owners can reduce this risk by building a defensible, CPA-grade EBITDA position 24\u201336 months before listing. That approach involves sustaining operational improvements that support the numbers and then running a competitive process that turns those gains into premium, non-renegotiated offers.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Find out where your practice stands today and what a realistic optimization runway looks like by scheduling a free discovery call with McLerran &amp; Associates.<\/strong><\/a><\/p>\n<h2>Prerequisites and Context: Owners Who Benefit Most From This Guide<\/h2>\n<p>This guide is written for owners of premier dental practices, generally $1M or more in annual revenue, who are 1\u20133 years from a possible exit and already familiar with basic valuation ideas. The frameworks below can apply whether you are considering a doctor-to-doctor sale or an affiliation with a DSO or private equity partner.<\/p>\n<p>Two valuation terms appear throughout this guide and benefit from clear definitions at the start.<\/p>\n<ul>\n<li>\n<p><strong>Reported EBITDA:<\/strong> The practice\u2019s earnings as shown on tax returns or financial statements, before interest, taxes, depreciation, and amortization are added back.<\/p>\n<\/li>\n<li>\n<p><strong>Normalized (Adjusted) EBITDA:<\/strong> Reported EBITDA plus legitimate add-backs, such as owner compensation above market rate, personal expenses run through the business, and one-time non-recurring costs, that reflect the practice\u2019s ongoing cash flow available to a new owner.<\/p>\n<\/li>\n<\/ul>\n<p>The gap between these two numbers can be where much of the value in a dental practice sale is created or lost. McLerran &amp; Associates has completed roughly 2,000 practice sales totaling approximately $2 billion in closed transaction volume, evaluated more than 10,000 practices, and achieves a transaction rate of approximately 85\u201390%, compared to an industry norm closer to 35\u201340%. That track record rests on CPA-led EBITDA analysis completed before the deal goes to market, so the numbers tend to hold when buyers scrutinize them.<\/p>\n<h2>Step-by-Step Process: 24-Month EBITDA Optimization Timeline<\/h2>\n<p>This 24\u201336 month sequence reflects a diligence-first approach that builds documentation and sustainable performance before going to market. The minimum useful preparation window is usually 12 months, which gives time to create trailing data that can withstand buyer QoE review.<\/p>\n<ol>\n<li>\n<p><strong>Clean financials and tag add-backs in real time (T-36 to T-24).<\/strong> Switch to accrual-basis accounting, reconcile your practice management software (PMS) data to bank deposits, and tag every potential add-back as it occurs, with the supporting invoice, payroll record, or receipt attached. Institutional buyers typically request 5 years of claim-level PMS data and 3 years of CPA-prepared financial statements, so unreconciled gaps often become the first diligence questions. Build a line-by-line bridge from book EBITDA to adjusted EBITDA early, rather than a few months before listing.<\/p>\n<\/li>\n<li>\n<p><strong>Normalize owner compensation and related-party expenses using market benchmarks (T-30 to T-24).<\/strong> Owner compensation above market rate is often the largest and most widely accepted add-back in dental practice EBITDA normalization. Defending this position requires a documented market compensation analysis, meaning a comparison of what you paid yourself versus what a replacement associate of similar production would cost in your area. Commission this analysis before diligence begins. Apply similar discipline to related-party rent, supported by a fair market value appraisal, family member payroll, supported by job descriptions and market benchmarks for the above-market portion only, and personal expenses such as vehicles, club memberships, and travel, supported by 36 months of records.<\/p>\n<\/li>\n<li>\n<p><strong>Lift hygiene production to 28\u201335% of collections and raise recall to 85%+ (T-24 to T-12).<\/strong> Hygiene often forms the backbone of recurring EBITDA. Raising hygiene recall from the national average of 65\u201374% to 85%+ can generate meaningful incremental annual production. At 30\u201340% EBITDA flow-through and a representative multiple, that production gain can create substantial additional enterprise value. A hygiene reappointment rate of 90%+ signals recurring revenue stability that can support premium valuation multiples, because it shows predictable patient retention that does not depend solely on the selling dentist.<\/p>\n<\/li>\n<li>\n<p><strong>Expand high-margin procedures and renegotiate or drop toxic PPOs (T-24 to T-12).<\/strong> Expanding implant and periodontal procedures, which often carry 55\u201368% gross margins, can add 2\u20134 EBITDA points without proportional overhead increases. On the payer side, fee schedule improvements are one of the few revenue gains that require no additional patients, no extra chair time, and no extra team capacity, so they flow directly to EBITDA. Inventory all PPO contracts, calculate net revenue contribution per carrier, and exit the lowest-ratio plans in a phased way. Practices planning a sale within 24 months can benefit from completing PPO transitions and allowing 12\u201318 months of stabilized post-drop revenue before going to market, because a mid-transition practice with active attrition is harder to value.<\/p>\n<\/li>\n<li>\n<p><strong>Reduce owner dependency below 35% of production through associates (T-24 to T-12).<\/strong> Heavily owner-dependent practices, where a single provider produces more than 90% of total revenue, often experience a documented 10\u201320% valuation haircut even from sophisticated buyers. Adding a full-time associate at least 18\u201324 months before a planned sale can be one of the highest-return pre-sale investments. This shift can move the valuation framework from seller\u2019s discretionary earnings (SDE) to EBITDA, which often supports higher multiples, and it creates associate-adjusted EBITDA documented across multiple fiscal years.<\/p>\n<\/li>\n<li>\n<p><strong>Run a sell-side quality-of-earnings review 6\u201312 months before listing (T-12 to T-6).<\/strong> A sell-side QoE is a formal, independent audit of your normalized EBITDA completed on your behalf before the buyer\u2019s team arrives. An independent QoE analysis for a single-practice dental transaction typically costs <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.thesorso.com\/answers\/qoe-report-cost-medical-practice\">$35,000 or more<\/a> and can protect purchase price by 10\u201320 times that amount by anchoring the seller\u2019s EBITDA position. It can also surface compliance vulnerabilities, such as CDT coding patterns that deviate from national benchmarks, before the buyer\u2019s team finds them and uses them to renegotiate the deal.<\/p>\n<\/li>\n<\/ol>\n<p>Each of these six steps requires different lead times and expertise. <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Discuss which levers will move the needle most for your specific practice in a confidential call with McLerran &amp; Associates.<\/strong><\/a><\/p>\n<h2>EBITDA Add-Back Examples and Buyer-Type Differences<\/h2>\n<p>The table below illustrates common add-back categories, the documentation needed to defend them, and the approximate value at risk if buyers reject them. Notice that every category benefits from contemporaneous documentation, not records assembled after a buyer asks for them. Dollar figures are illustrative, and actual amounts depend on practice size and buyer type.<\/p>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Add-Back Category<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Documentation Required<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Typical Annual Range<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Owner compensation above market rate<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Market-rate compensation survey, state and specialty benchmarks<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$100K\u2013$300K<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Family member payroll above market rate<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Job descriptions, market compensation benchmarks for the above-market portion only<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>No specific typical annual range for family-member payroll above-market-rate add-backs is stated, and such add-backs are evaluated case-by-case against published market compensation data<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Above-market related-party rent<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Independent FMV appraisal showing the difference from market rate<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Varies by lease terms and market rates<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Personal expenses (vehicles, travel, meals, family payroll, and personal insurance)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>36 months of credit card statements and receipts with business justification<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically total <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.thesorso.com\/answers\/ebitda-add-backs-practice-valuation\">$30K to $150K<\/a> per year as an EBITDA add-back in dental practices<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>One-time non-recurring expenses<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Invoices, legal records, and an explanation of the non-recurring nature verified across multiple years<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Varies by event<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>These add-backs matter because buyer type can influence how they are valued. Private buyers, meaning individual dentists, often value practices using a percentage of annual collections or a multiple of SDE, while institutional buyers typically apply EBITDA multiples. A $2 million revenue practice with 20% EBITDA margins, or $400,000 EBITDA, valued at 6\u20137 times EBITDA can transact at $2.4M\u2013$2.8M to an institutional buyer, compared to $1.3M\u2013$1.7M at 65\u201385% of collections to a private buyer. That comparison shows how the buyer pool and the competitive process that surfaces it can matter as much as the EBITDA number itself.<\/p>\n<p>McLerran &amp; Associates\u2019 structured, auction-style bid process, usually 45\u201360 days and generating around 10 offers from a vetted pool of buyers, is the mechanism that can convert EBITDA gains into premium, non-renegotiated offers. Poorly performing or unreliable buyers are screened out before the process begins, so owners see the real market and negotiate from a stronger position.<\/p>\n<h2>Common Challenges and Troubleshooting<\/h2>\n<p>Three recurring pitfalls account for much of the value lost between a seller\u2019s expectations and the final closing price.<\/p>\n<ul>\n<li>\n<p><strong>Undocumented or aggressive add-backs.<\/strong> Every add-back claimed during EBITDA normalization will be scrutinized during buyer due diligence. If a buyer rejects even one aggressive assumption, they can begin questioning all other add-backs, which is why each adjustment benefits from being conservative, defensible, and supported by contemporaneous documentation rather than assembled retroactively.<\/p>\n<\/li>\n<li>\n<p><strong>Incomplete three-year financial and PMS history.<\/strong> Institutional buyers often conduct a three-year P&amp;L analysis and a five-year PMS audit, creating a data window that 12-month preparation usually cannot compress. Corrections implemented close to the sale date can appear as pre-sale manipulation in buyer algorithms and may trigger larger indemnification escrows.<\/p>\n<\/li>\n<li>\n<p><strong>Temporary margin pressure during PPO transitions.<\/strong> Overhead often rises during PPO reduction as patient volume adjusts. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/dentalpracticeinsider.org\/ppo-drop-economics\">Practices can track line-item benchmarks weekly within the first 30 days post-drop<\/a> to validate transition assumptions before moving to the next carrier. A mid-transition practice with ongoing attrition is harder to value and can deter buyers who prefer predictable insurance revenue.<\/p>\n<\/li>\n<\/ul>\n<h2>Measuring Success: Valuation Quality and Diligence Outcomes<\/h2>\n<p>The goal of a 24-month optimization program is a normalized EBITDA figure that can withstand buyer scrutiny and support a premium multiple in a competitive process, rather than simply a higher spreadsheet number. Every dollar of sustainable EBITDA improvement is multiplied by the applicable transaction multiple, so a $100,000 annual EBITDA improvement at a 6-times multiple creates $600,000 in enterprise value.<\/p>\n<p>Clean, defensible EBITDA combined with McLerran &amp; Associates\u2019 competitive auction process can produce offers that are both higher and more durable. Because McLerran\u2019s CPA-led analysis is diligence-grade work completed before the deal goes to market, the agreed value is more likely to hold when the buyer\u2019s QoE team arrives. If a buyer attempts to renegotiate, McLerran can remind them that other vetted bidders are still in the process.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What are the most defensible add-backs in a dental practice EBITDA normalization?<\/h3>\n<p>The most widely accepted add-backs usually fall into two groups. Hard add-backs, such as depreciation and amortization, debt service retired at close, and genuinely one-time expenses like litigation settlements or emergency equipment replacement, are often accepted by institutional buyers when supported by documentation. Soft add-backs require more support. Owner compensation above the market rate for a replacement associate of similar production is usually the largest single adjustment and the most contested, so it benefits from a formal market compensation analysis. Related-party rent above fair market value needs an independent appraisal. Family member payroll typically qualifies only for the above-market portion, supported by job descriptions and market benchmarks. Personal expenses such as vehicles, travel, and club memberships require receipts and a clear explanation of their personal nature. A practical discipline is building a one-page defense file per add-back, including a description, annual dollar amount, supporting documentation, and logic, before diligence begins.<\/p>\n<h3>How much can hygiene optimization realistically move normalized EBITDA?<\/h3>\n<p>Hygiene optimization can have a substantial impact that compounds across several levers. As discussed in the optimization timeline, lifting recall to 85%+ can generate tens of thousands of dollars in incremental annual production, which then flows through to EBITDA at 30\u201340% margins and is multiplied by the applicable transaction multiple at exit. Adjunctive services such as fluoride, antimicrobial agents, and laser-assisted periodontal therapy can increase per-visit production without adding chair time. Reaching the benchmark of hygiene production at 28\u201335% of total collections also signals to DSO buyers that the practice generates recurring revenue independent of the selling dentist, which can support a higher multiple. The full value of hygiene optimization usually requires 12\u201318 months of sustained performance in the financial statements to be credible in a QoE review.<\/p>\n<h3>What EBITDA multiples should owners of $1M+ revenue practices expect in 2025\u20132026?<\/h3>\n<p>EBITDA multiples can vary significantly by practice size, buyer type, payer mix, owner dependency, and specialty. As a planning reference, solo general dental practices sold to individual private buyers have historically transacted at lower multiples than institutional buyer transactions. Institutional buyers often apply EBITDA multiples that scale with practice size, with smaller add-on acquisitions at the lower end of the range and scaled, associate-led, multi-location groups at the higher end. Specialty practices can carry a premium over equivalent-sized general dentistry practices. Payer mix can drive 1\u20132 turns of variance within any band, with fee-for-service-dominant practices near the top of ranges and heavily PPO-dependent or Medicaid-heavy practices near the bottom. The specific multiple for any practice depends on its numbers, market, and buyer pool, which is what a CPA-led valuation and competitive process are designed to quantify and improve. Consulting a qualified dental M&amp;A advisor before drawing conclusions from published ranges alone can be helpful.<\/p>\n<h3>What is the minimum timeline for EBITDA gains to be credible in buyer diligence?<\/h3>\n<p>Most experienced advisors recommend a 24\u201336 month runway, with 12 months as the practical minimum for high-leverage improvements. Institutional buyers often audit 3 years of financial statements and up to 5 years of PMS data, so an improvement implemented 14 months before sale shows only 14 months of compliant history against a longer prior record, which buyer algorithms can flag as pre-sale manipulation. Key levers that usually require the longest runway include lifting hygiene recall from below average to 85%+, reducing owner production dependency below 35%, renegotiating or dropping PPO contracts and allowing post-transition revenue to stabilize, and onboarding associates with enough history to document associate-adjusted EBITDA across multiple fiscal years. Fee schedule adjustments and accounts receivable recovery campaigns can show results within 1\u20133 months, but they still benefit from trending across 12\u201324 months of financial statements to support the optimized valuation scenario in a QoE review.<\/p>\n<h2>Conclusion: Turn EBITDA Gains into a Premium Exit<\/h2>\n<p>Maximizing EBITDA before selling your dental practice functions as a 24\u201336 month discipline rather than a short pre-listing checklist. The work includes cleaning up financials and tagging add-backs in real time, normalizing owner compensation with documented market benchmarks, building a hygiene department that generates recurring revenue independent of the selling dentist, expanding high-margin procedures, improving the payer mix, reducing owner dependency through associates, and running a sell-side QoE review before the buyer\u2019s team arrives. Each step can compound the others, and each improvement can be worth several times its annual dollar value at the applicable transaction multiple.<\/p>\n<p>These gains only translate into seller proceeds when they survive buyer scrutiny and are competed for by a vetted pool of qualified buyers. At that point, CPA-led normalization and a structured competitive process can become central drivers of outcome. McLerran &amp; Associates has built a reputation as the premier listing agent for premier dental practices through the track record described earlier, largely because the firm completes diligence-grade work up front and then creates the competition that can convert it into premium, non-renegotiated offers.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Schedule a free, confidential discovery call with McLerran &amp; Associates<\/strong><\/a> to discuss your practice, your goals, and what a realistic 24-month optimization roadmap can look like for your situation. Call <strong>(512) 900-7989<\/strong>, email <strong>info@dentaltransitions.com<\/strong>, or visit the <strong>contact page<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Discover strategies to boost dental EBITDA before a sale. McLerran&#8217;s CPA-led analysis and competitive buyer process can maximize your exit value.<\/p>\n","protected":false},"author":1,"featured_media":143,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=144"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/143"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}